Uni Medicolabs

Manufacturing Facilities

We are Committed To Excellence in Quality, Cutting-Edge Technology, & A Drive For Advancing Healthcare. ​

We operate 3 production facilities located in Dehradun, Uttarakhand. 2 of the facilities are awaiting EU-GMP approvals.

Uni Medicolabs currently commercializes its products in SE Asia, Indian Subcontinent, South America, MENA region and Africa.

With a highly experienced team in place and capacities available across our sites, we have several long-standing contract manufacturing partnerships and are open to collaborating for new business opportunities.

Penicillin Block

Located in Dehradun, this state-of-the-art plant is a dedicated Penicillin facility. Set up in 2009 it has a built-up area of 5000 sq. meters and has a 150+ strong workforce. This facility has industry-leading expertise to manufacture products like Co-AmoxiClav. Already catering to patients in key emerging markets it is also in the process of getting EU-GMP approval. With cGMP-compliant stringent controls in place to avoid cross-contamination, the facility also consists of a sterile dry powder line, with an annual capacity of 15 million vials.

Approvals : FDA Philippines, Drug Administration Vietnam, PPB Kenya, NAFDAC Nigeria, NDA Uganda, NMRA Sri Lanka

Capsule
Tablets
Dry Powder Injection
Dry Powder Syrup

General Block 1

This State of the art Facility has a built-up area of 7000 sq. meters and has a 200+ strong workforce. It has the latest manufacturing equipment and is designed for commercial batch sizes ranging from 6kg to 2000 kg. It has Tablets, Capsules and Liquid lines. The site is currently in the process of getting EU-GMP approval and is currently catering to SE Asia and the MENA region.

Approvals : FDA Philippines, Drug Administration Vietnam, PPB Kenya, NAFDAC Nigeria, NDA Uganda, NMRA Sri Lanka

Capsule
Tablets
Liquid Oral Bottles

General Block 2

Uni Medicolabs acquired this facility from Unichem Laboratories in 2018. This unit is located in an area covering over 8100 square meters and has a built-up area of 3000 square meters. It can manufacture Tablets, Capsules, Dry Powder Syrups and Dry Powder Sachet.

Approvals : WHO-GMP

Capsule
Tablets
Dry Powder Syrup
Sachets
Tablets

5 Billion

Tablets

2 Billion

Capsules

Injection

25 Million

DPI Vials

Dry Syrup

20 Million

Dry Powder Syrup

Sachets

50 Million

Sachets

Liquid Bottles

25 Million

Oral Liquid Bottles

Tablets

5 Billion

Tablets

2 Billion

Capsules

Injection

25 Million

Injectable Vials

Dry Syrup

20 Billion

Dry Syrup

Sachets

50 Million

Sachets

Liquid Bottles

25 Million

Liquid Bottles